CITADEL ADVISORS LLC

Position in SNGX — Soligenix, Inc.

CIK 1423053 MIAMI, FL

Position in SNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$83,802

+$63,943 QoQ

Shares Held

209,507

+1282.0% QoQ

Ownership

0.963%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,086,778,995 across 435 Biotechnology names. SNGX ranks #362 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$83,802	209,507	+1282.0%	Shares	Defined	2026-08-14
2025-06-30	$19,859	15,160	-14.6%	Shares	Defined	2025-08-14
2023-12-31	$13,484	17,743	-72.3%	Shares	Defined	2024-02-14
2022-12-31	$28,806	64,015	+200.6%	Shares	Defined	2023-02-14
2021-12-31	$14,054	21,295	-90.2%	Shares	Defined	2022-02-14
2021-09-30	$230,659	217,603	+166.1%	Shares	Defined	2021-11-15
2021-06-30	$90,766	81,772	-4.1%	Shares	Defined	2021-08-16
2021-03-31	$130,487	85,286	+300.2%	Shares	Defined	2021-05-21
2020-09-30	$38,143	21,309	+85.4%	Shares	Defined	2020-11-16
2020-06-30	$24,246	11,491	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.